Oxytocin 30 Units/500 mL in 0 — Class I drug recall D-0015-2026
Ongoing recall by IntegraDose Compounding Services LLC, reported 2025-10-22, distributed nationwide. Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.
| Recall number | D-0015-2026 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | IntegraDose Compounding Services LLC, Minneapolis, MN, United States |
| Recall initiated | 2025-09-16 |
| Classified | 2025-10-10 |
| Reported by FDA | 2025-10-22 |
| Distributed | Nationwide (US) |
| Quantity | 853 |
| Reason classes | potency |
| NDC | 71139-0012-01 |
| Lot numbers | 20250620OXY-1 |
| Expiration dates | 2025-10-18 |
Product
Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842 NDC 71139-0012-1
Reason for recall
Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0015-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.